Asymmetrie synthesis of 1,1-diarylalkyl units by a copper hydride catalyzed reduction: Differentiation between two Similar aryl substituents

Chemistry - A European Journal

Volumn 15, Issue 42, 2009, Pages 11134-11138

  Yoo, Kihyun ^a   Kim, Hyohyun ^a   Yun, Jaesook ^a  

^a Institute for Basic Science   (South Korea)

Author keywords

Asymmetric catalysis; Copper; Enantioselectivity; Reduction; Silanes

Indexed keywords

ARYL GROUP; ARYL SUBSTITUENTS; ASYMMETRIC CATALYSIS; COORDINATION SITES; COPPER HYDRIDES; EFFICIENT METHOD; ENANTIOMERIC EXCESS; ENANTIOSELECTIVE; FERROCENYL; FORMAL SYNTHESIS; LIGAND EFFECT; UNSATURATED NITRILES;

CATALYSIS; COORDINATION REACTIONS; COPPER COMPOUNDS; CYANIDES; ELECTRON TRANSITIONS; ENANTIOSELECTIVITY; SILANES; SUBSTITUTION REACTIONS;

COPPER;

COPPER; INDAN DERIVATIVE; INDATRALINE; METHYLAMINE; NITRILE; SILANE DERIVATIVE;

ARTICLE; CATALYSIS; CHEMISTRY; CONFORMATION; OXIDATION REDUCTION REACTION; STEREOISOMERISM; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

CATALYSIS; COPPER; CRYSTALLOGRAPHY, X-RAY; INDANS; METHYLAMINES; MOLECULAR CONFORMATION; NITRILES; OXIDATION-REDUCTION; SILANES; STEREOISOMERISM;

EID: 70350490775     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.200901262     Document Type: Article

References (35)

1. W. M. Welch, A. R. Kraska, R. Sarges, B. K. Koe, J. Med Chem. 1984, 27, 1508-1515.
2. a) N. Sugiyama, F. Akahoshi, S. Kuwahara, M. Kajii, Y. Sakaue, H. Yukumaru, M. Sugiura, C. Fukaya, J. Med Chem. 1994, 37, 1977-1982;
3. b) J. C. Anthes, H. Gilchrest, C. Richard, S. Eckel, D. Hesk, R. E. West, S. M. Williams, S. Greenfeder, M. Billah, W. Kreutner, R. W. Egan, Eur. J. Pharmacol. 2002, 449, 229-237.
4. a) C. Almansa, L. A. Gómez, F. L. Cavalcanti, A. F. de Arriba, R. Rodríguez, E. Carceller, J. García-Rafanell, J. Forn, J. Med. Chem. 1996, 39, 2197-2206;
5. b) P. C. Astles, T. J. Brown, F. Halley, C. M. Handscombe, N. V. Harris, T. N. Majid, C. McCarthy, I. M. McLay, A. Morley, B. Porter, A. G. Roach, C. Sargent, C. Smith, R. J. A. Walsh, J. Med. Chem. 2000, 43, 900-910.
6. J. L. Collins, A. M. Fivush, M. A. Watson, C. M. Galardi, M. C. Lewis, L. B. Moore, D. J. Parks, J. G. Wilson, T. K. Tippin, J. G. Binz, K. D. Plunket, D. G. Morgan, E. J. Beaudet, K. D. Whitney, S. A. Kliewer, T. M. Willson, J. Med. Chem. 2002, 45, 1963-1966.
7. a) S. T. Moe, D. L. Smith, E. G. DelMar, S. M. Shimizu, B. C. Van Wagenen, M. F. Balandrin, Y. Chien, J. L. Raszkiewicz, L. D. Artman, H. S. White, A. L. Mueller, Bioorg. Med. Chem. Lett. 2000, 10, 2411-2415;
8. b) J. G. Cumming, A. E. Cooper, K. Grime, C. J. Logan, S. McLaughlin, J. Oldfield, J. S. Shaw, H. Tucker, J. Winter, D. Whittaker, Bioorg. Med. Chem. Lett. 2005, 15, 5012-5015;
9. c) A. Bedini, G. Spadoni, G. Gatti, S. Lucarini, G. Tarzia, S. Rivara, S. Lorenzi, A. Lodola, M. Mor, V. Lucini, M. Pannacci, F. Scaglione, J. Med. Chem. 2006, 49, 7393-7403;
10. d) L. Nilvebrant, K.-E. Andersson, P.-G. Gillberg, M. Stahl, B. Sparf, Eur. J. Pharmacol. 1997, 327, 195-207.
11. Y. Bolshan, C. Chen, J. R. Chilenski, F. Gosselin, D. J. Mathre, P. D. O'Shea, A. Roy, R. D. Tillyer, Org. Lett. 2004, 6, 111-114.
12. a) J.-F. Paquin, C. Defieber, C. R. J. Stephenson, E. M. Carreira, J. Am. Chem. Soc. 2005, 227, 10850-10851;
13. b) J.-F. Paquin, C. R. J. Stephenson, C. Defieber, E. M. Carreira, Org. Lett. 2005, 7, 3821-3824;
14. c) S. Sörgel, N. Tokunaga, K. Sasaki, K. Okamoto, T. Hayashi, Org. Lett. 2008, 10, 589-592;
15. d) N. Tokunaga, T. Hayashi, Tetrahedron: Asymmetry 2006, 17, 607-613;
16. e) T. Nishikata, Y. Yamamoto, I.D. Gridnev, N. Miyaura, Organometallics 2005, 24, 5025-5032;
17. f) T. Nishikata, Y. Yamamoto, N. Miyaura, Tetrahedron Lett. 2007, 48, 4007-4010.
18. a) P. Bissel, R. Sablong, J.-P. Lepoittevin, Tetrahedron: Asymmetry 1995, 6, 835-838;
19. b) M. A. McGuire, S. C. Shilcrat, E. Sorenson, Tetrahedron Lett. 1999, 40, 3293-3296;
20. c) L. T. Boulton, I. C. Lennon, R. McCague, Org. Biomol. Chem. 2003, 2, 1094-1096;
21. d) T. C. Wabnitz, S. Rizzo, C. Götte, A. Buschauer, T. Benincori, O. Reiser, Tetrahedron Lett. 2006, 47, 3733-3736.
22. D. Lee, Y. Yang, J. Yun, Org. Lett. 2007, 9, 2749-2751; one example of a β,β-diaryl-substituted case was reported therein.
23. J. Masllorens, M. Moreno-Mañas, A. Pla-Quintana, R. Pleixats, A. Roglans, Synthesis 2002, 1903-1911.
24. S. J. Taylor, M. R. Netherton, J. Org. Chem. 2006, 71, 397-400.
25. Y. Yamamoto, N. Kirai, Y. Harada, Chem. Commun. 2008, 2010-2012.
26. Optical rotation values for 2b, 2d, and 2i are known; see the Supporting Information for details.
27. 2, R1 = 0.0721, wR2 = 0.1291. CCDC643511 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data- request/cif
28. F. López, S. R. Harutyunyan, A. Meetsma, A. J. Minnaard, B. L. Feringa, Angew. Chem. 2005, 117, 2812-2816;
29. Angew. Chem. Int. Ed. 2005, 44, 2752-2756.
30. Discrete copper hydride complexes coordinated with bidentate phosphine ligands have not been reported so far. For an isolated Nheterocyclic carbene bound copper hydride complex, see: N. P. Mankad, D. S. Laitar, J. P. Sadighi, Organometallics 2004, 23, 3369-3371.
31. a) B. H. Lipshutz, K. Noson, W. Chrisman, A. Lower, J. Am. Chem. Soc. 2003, 225, 8779-8789;
32. b) J.-X. Chen, J. F. Daeuble, D. M. Brestensky, J. M. Stryker, Tetrahedron 2000, 56, 2153-2166.
33. 2/3 (2 mol%) in the presence of PMHS, tBuOH, and acetonitrile.
34. K. P. Bogeso, A. V. Christensen, J. Hyttel, T. Liljefors, J. Med. Chem. 1985, 28, 1817-1828.
35. H. M. L. Davies, T. M. Gregg, Tetrahedron Lett. 2002, 43, 4951-4953.